While it remains to be seen whether ANGPT2 is similarly affected, and potentially targetable, in murine models of sporadic bAVM, this may represent a shared therapeutic vulnerability and common mechanism in inherited and sporadic bAVM. The gene discussed is ANGPT2; the disease is arteriovenous malformations of the brain.